title: Prostaglandins in patients with pulmonary hypertension: the route of administration.
authors.forename: M
authors.initials: M
authors.lastname: Booke
authors.forename: H
authors.initials: H
authors.lastname: Van Aken
authors.forename: G
authors.initials: G
authors.lastname: Theilmeier
authors.forename: J
authors.initials: J
authors.lastname: Meyer
mesh_terms: D000280:Administration, Inhalation; D000527:Alprostadil / Q000008:administration & dosage*; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D001794:Blood Pressure / Q000187:drug effects; D011464:Epoprostenol / Q000008:administration & dosage*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D007275:Injections, Intravenous; D009330:Nebulizers and Vaporizers; D011651:Pulmonary Artery / Q000187:drug effects; D012128:Respiratory Distress Syndrome / Q000188:drug therapy; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000008:administration & dosage*; D014692:Ventilation-Perfusion Ratio / Q000187:drug effects
chemical_list: D000959:Antihypertensive Agents; D014665:Vasodilator Agents; D011464:Epoprostenol; D000527:Alprostadil